DuPont launches AmberChrom SIL for peptide purification, including GLP-1 agonists
DuPont de Nemours launched AmberChrom SIL, a silica gel for reversed-phase chromatography with C8 and C18 chemistries intended for peptide purification, including GLP-1 receptor agonists. According to the company, the product aims to support workflows from crude product through polishing and scalability. The announcement was distributed by PR Newswire.
In 25 seconds
- DuPont introduced AmberChrom SIL, a silica gel for reversed-phase chromatography
- The medium offers C8 and C18 chemistries to purify peptides, including GLP-1 receptor agonists
- The company targets workflows from crude product through polishing and scalability
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.